G'day everyone!! Hope you are all well.
This 4C result was obviously a step in the right direction - after a good result for the Jan to March 2020 quarter just before the CR (funny that![]()
), & then a bit of a shocker report for the April to June 2020 quarter (after the CR).
In this July to September 2020 4C & subsequent results presentation, there is now (suddenly) a large focus on EBITDA (which is good), but just about every time revenue was discussed they compared it to Q 4 FY20 (which was a really low revenue quarter).
Revenue has gone backwards a little from last year - which is as a result of dropping the unprofitable product lines, and also COVID disrupting the aged care side of the business (revenue down 13% in aged care versus previous quarter).
All the talk about the growing sales pipelines / tenders in mining & aged care was encouraging - as there is no doubt that this business needs a lot more scale to really improve their gross profit margins.
Overall, the professionalism of the reports were outstanding - so maybe this is the influence of the new CFO?
I hold a stack of SW1 shares, and will continue holding on the back of this report - as the market cap is ridiculously low at less than 1 x revenue.
However, they really need to scale up in a profitable way - as EBITDA does not equal profit in this company (due largely to a lot of shares being issued each year).
And I do worry that Pippa thinks it will be quite easy to go back to the market for another capital raise - and at these prices that would definitely not be welcomed.
Here's hoping that they start to announce some good wins ASAP in both mining & aged care - as that would certainly be a major positive for the SP.
Good luck everyone!!
- Forums
- ASX - By Stock
- SW1
- Ann: Strong Q1 FY21 Results Quarterly Report and Cash Flow
Ann: Strong Q1 FY21 Results Quarterly Report and Cash Flow, page-14
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SW1 (ASX) to my watchlist
|
|||||
Last
1.8¢ |
Change
-0.001(2.78%) |
Mkt cap ! $11.35M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $175 | 10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 25797 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.017 |
1 | 200300 | 0.016 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 25797 | 1 |
0.021 | 1649 | 1 |
0.023 | 43160 | 2 |
0.024 | 500000 | 1 |
0.025 | 100000 | 1 |
Last trade - 13.52pm 15/07/2024 (20 minute delay) ? |
Featured News
SW1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online